Cargando…
BCG-activation of leukocytes is sufficient for the generation of donor-independent innate anti-tumor NK and γδ T-cells that can be further expanded in vitro
Bacillus Calmette-Guérin (BCG), the nonpathogenic Mycobacterium bovis strain used as tuberculosis vaccine, has been successfully used as treatment for non-muscle invasive bladder cancer for decades, and suggested to potentiate cellular and humoral immune responses. However, the exact mechanism of ac...
Autores principales: | Esteso, Gloria, Felgueres, María José, García-Jiménez, Álvaro F., Reyburn-Valés, Christina, Benguría, Alberto, Vázquez, Enrique, Reyburn, Hugh T., Aguiló, Nacho, Martín, Carlos, Puentes, Eugenia, Murillo, Ingrid, Rodríguez, Esteban, Valés-Gómez, Mar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9788708/ https://www.ncbi.nlm.nih.gov/pubmed/36567803 http://dx.doi.org/10.1080/2162402X.2022.2160094 |
Ejemplares similares
-
NKG2D is a Key Receptor for Recognition of Bladder Cancer Cells by IL-2-Activated NK Cells and BCG Promotes NK Cell Activation
por: García-Cuesta, Eva María, et al.
Publicado: (2015) -
Natural Killer Anti-Tumor Activity Can Be Achieved by In Vitro Incubation With Heat-Killed BCG
por: Esteso, Gloria, et al.
Publicado: (2021) -
Expression of the UL16 glycoprotein of Human Cytomegalovirus protects the virus-infected cell from attack by natural killer cells
por: Valés-Gómez, Mar, et al.
Publicado: (2003) -
Human NKG2D-ligands: cell biology strategies to ensure immune recognition
por: Fernández-Messina, Lola, et al.
Publicado: (2012) -
Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors
por: Moreo, Eduardo, et al.
Publicado: (2022)